| Literature DB >> 21677507 |
M A Minetto1, F Lanfranco, G Motta, S Allasia, E Arvat, G D'Antona.
Abstract
Steroid myopathy is a non-inflammatory toxic myopathy that occurs as side effect of exogenous and endogenous glucocorticoid excess. The purpose of this review is to examine issues that limit our understanding of this myopathy with respect to nosology, etiopathogenesis, conditioning factors, and muscle fiber selectivity. We suggest that if more data were available on these issues, the understanding of steroid myopathy would be enhanced substantially, thus allowing an early detection of its occurrence (before the appearance of clinical or laboratory signs) and a proper treatment of the patients.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21677507 DOI: 10.1007/BF03347462
Source DB: PubMed Journal: J Endocrinol Invest ISSN: 0391-4097 Impact factor: 4.256